The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 14, 2024 | Leonard Braden Michael | 10% Owner | Buy(P) | 297K | $1.30 | $386K |
| May 13, 2024 | Leonard Braden Michael | 10% Owner | Buy(P) | 254K | $1.24 | $315K |
| May 13, 2024 | Leonard Braden Michael | 10% Owner | Buy(P) | 216K | $1.26 | $272K |
| Feb 5, 2024 | Avruch Steven | Chief Legal Officer | Tax withholding(F) | 11K | $1.20 | $13K |
| Feb 5, 2024 | Ostrowski Erik | Interim CEO, President and CFO | Tax withholding(F) | 13K | $1.20 | $16K |
| Feb 5, 2024 | Ridha Essra | Chief Medical Officer | Tax withholding(F) | 17K | $1.20 | $20K |
| Feb 5, 2024 | Golipour Azadeh | Chief Technology Officer | Tax withholding(F) | 12K | $1.20 | $15K |
| Feb 1, 2024 | Avruch Steven | Chief Legal Officer | Option exercise(M) | 33K | — | $0 |
| Feb 1, 2024 | Avruch Steven | Chief Legal Officer | Option exercise(M) | 33K | — | $0 |
| Feb 1, 2024 | Ostrowski Erik | Interim CEO, President and CFO | Option exercise(M) | 40K | — | $0 |
| Feb 1, 2024 | Ostrowski Erik | Interim CEO, President and CFO | Option exercise(M) | 40K | — | $0 |
| Feb 1, 2024 | Ridha Essra | Chief Medical Officer | Option exercise(M) | 33K | — | $0 |
| Feb 1, 2024 | Ridha Essra | Chief Medical Officer | Option exercise(M) | 33K | — | $0 |
| Feb 1, 2024 | Golipour Azadeh | Chief Technology Officer | Option exercise(M) | 37K | — | $0 |
| Feb 1, 2024 | Golipour Azadeh | Chief Technology Officer | Option exercise(M) | 37K | — | $0 |
| Jul 1, 2023 | Ostrowski Erik | Interim CEO, President and CFO | Grant(A) | 70K | — | $0 |
| Jun 12, 2023 | Golipour Azadeh | Chief Technology Officer | Tax withholding(F) | 5K | $1.19 | $7K |
| Jun 12, 2023 | Golipour Azadeh | Chief Technology Officer | Tax withholding(F) | 111 | $1.21 | $134 |
| Jun 6, 2023 | Clark Ian T | Director | Grant(A) | 18K | — | $0 |
| Jun 6, 2023 | Jenkins Annalisa | Director | Grant(A) | 18K | — | $0 |
| Jun 6, 2023 | Booth Bruce | Director | Grant(A) | 18K | — | $0 |
| Jun 6, 2023 | Farfel Gail M | Director | Grant(A) | 18K | — | $0 |
| Jun 6, 2023 | Vickers Philip J. | Director | Grant(A) | 18K | — | $0 |
| Jun 6, 2023 | Donenberg Phillip B. | Director | Grant(A) | 18K | — | $0 |
| Jun 6, 2023 | Paige Christopher | Director | Grant(A) | 18K | — | $0 |
| Feb 8, 2023 | Avruch Steven | Chief Legal Officer | Grant(A) | 131K | — | $0 |
| Feb 8, 2023 | Mackay Geoffrey | President & CEO, Director | Grant(A) | 301K | — | $0 |
| Feb 8, 2023 | Golipour Azadeh | Chief Technology Officer | Grant(A) | 149K | — | $0 |
| Feb 8, 2023 | Ostrowski Erik | Chief Financial Officer | Grant(A) | 160K | — | $0 |
| Feb 8, 2023 | Ridha Essra | Chief Medical Officer | Grant(A) | 131K | — | $0 |
| Feb 8, 2023 | Petersen Deanna M | Chief Business Officer | Grant(A) | 87K | — | $0 |
| Jan 24, 2023 | Mackay Geoffrey | President & CEO, Director | Option exercise(M) | 46K | $0.91 | $42K |
| Jan 24, 2023 | Mackay Geoffrey | President & CEO, Director | Option exercise(M) | 46K | — | $0 |
| Dec 28, 2022 | Mackay Geoffrey | President & CEO, Director | Gift(G) | 245K | — | $0 |
| Dec 28, 2022 | Mackay Geoffrey | President & CEO, Director | Gift(G) | 245K | — | $0 |
| Dec 23, 2022 | Mackay Geoffrey | President & CEO, Director | Option exercise(M) | 142K | $0.41 | $58K |
| Dec 23, 2022 | Mackay Geoffrey | President & CEO, Director | Option exercise(M) | 142K | — | $0 |
| Dec 8, 2022 | Avruch Steven | Chief Legal Officer | Grant(A) | 170K | — | $0 |
| Dec 8, 2022 | Golipour Azadeh | Chief Technology Officer | Grant(A) | 165K | — | $0 |
| Dec 8, 2022 | Ostrowski Erik | Chief Financial Officer | Grant(A) | 221K | — | $0 |
| Dec 8, 2022 | Mackay Geoffrey | President & CEO, Director | Grant(A) | 388K | — | $0 |
| Dec 8, 2022 | Petersen Deanna M | Chief Business Officer | Grant(A) | 112K | — | $0 |
| Dec 8, 2022 | Ridha Essra | Chief Medical Officer | Grant(A) | 183K | — | $0 |
| Jun 8, 2022 | Booth Bruce | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Booth Bruce | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Jenkins Annalisa | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Jenkins Annalisa | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Farfel Gail M | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Farfel Gail M | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Vickers Philip J. | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Vickers Philip J. | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Clark Ian T | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Clark Ian T | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Donenberg Phillip B. | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Donenberg Phillip B. | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Paige Christopher | Director | Grant(A) | 17K | — | $0 |
| Jun 8, 2022 | Paige Christopher | Director | Grant(A) | 17K | — | $0 |
| Feb 2, 2022 | Ostrowski Erik | Chief Financial Officer | Grant(A) | 170K | — | $0 |
| Feb 2, 2022 | Ostrowski Erik | Chief Financial Officer | Grant(A) | 145K | — | $0 |
| Feb 2, 2022 | Avruch Steven | Chief Legal Officer | Grant(A) | 90K | — | $0 |
| Feb 2, 2022 | Avruch Steven | Chief Legal Officer | Grant(A) | 105K | — | $0 |
| Feb 2, 2022 | Ridha Essra | Chief Medical Officer | Grant(A) | 80K | — | $0 |
| Feb 2, 2022 | Ridha Essra | Chief Medical Officer | Grant(A) | 75K | — | $0 |
| Feb 2, 2022 | Mackay Geoffrey | President & CEO, Director | Grant(A) | 405K | — | $0 |
| Feb 2, 2022 | Mackay Geoffrey | President & CEO, Director | Grant(A) | 329K | — | $0 |
| Feb 2, 2022 | Petersen Deanna M | Chief Business Officer | Grant(A) | 80K | — | $0 |
| Feb 2, 2022 | Petersen Deanna M | Chief Business Officer | Grant(A) | 100K | — | $0 |
| Nov 1, 2021 | Ridha Essra | Chief Medical Officer | Grant(A) | 120K | — | $0 |
| Jul 7, 2021 | Vickers Philip J. | Director | Buy(P) | 5K | $8.35 | $40K |
| Jun 10, 2021 | Petersen Deanna M | Chief Business Officer | Grant(A) | 125K | — | $0 |
| Jun 10, 2021 | Mason Christopher | Chief Scientific Officer | Grant(A) | 125K | — | $0 |
| Jun 10, 2021 | Ostrowski Erik | Chief Financial Officer | Grant(A) | 125K | — | $0 |
| Jun 10, 2021 | Mackay Geoffrey | President & CEO, Director | Grant(A) | 125K | — | $0 |
| Jun 10, 2021 | Escolar Diana | Chief Medical Officer | Grant(A) | 50K | — | $0 |
| Jun 10, 2021 | Avruch Steven | Chief Legal Officer | Grant(A) | 125K | — | $0 |
| Jun 10, 2021 | Vickers Philip J. | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2021 | Farfel Gail M | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2021 | Clark Ian T | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2021 | Jenkins Annalisa | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2021 | Paige Christopher | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2021 | Booth Bruce | Director | Grant(A) | 17K | — | $0 |
| Jun 10, 2021 | Donenberg Phillip B. | Director | Grant(A) | 17K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).